David S. Smith, a member of Pepper Hamilton's Health Sciences Department, will be speaking at the 12th annual Business of Regenerative Medicine conference taking place at Harvard Business School on July 15–16, 2019. On July 15, Mr. Smith will be speaking on the topic "Introduction of the ARM Foundation for Cell & Gene Medicine and Its Economic Impact Study" and will be a panelist on the discussion titled "Measuring Value: Developing a Macroeconomic Model to Understand Potential Impact of Cell and Gene Medicine on Healthcare Systems."
Over two days of panel discussions, presentations and networking, distinguished speakers will provide insights – as well as guardrails – for navigating the emerging industry of regenerative medicine. Speakers will explore how advances in cell and gene therapy, drug development, and bioengineering in regenerative medicine are moving from the lab to the patient – and what it will take to identify real, lasting value for business and society.